MondaySep 25, 2023 11:15 am

Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) Commences Diamond Drilling with Third Drill Hole at PCH Project in Brazil

The global rare earth elements market is expected to grow from 167.99 million tons in 2023, and to 206.25 million tons by 2028 – growing at a CAGR of 4.19% Since starting the project, Appia has commenced diamond drilling in addition to its current reverse circulation and auger drilling campaigns Specimens from the drilling efforts will be submitted to SGS Geosol laboratory, with assays expected two months from submission The global rare earth elements (“REE”) market is expected to grow from 167.99 million tons in 2023 to 206.25 million tons by 2028 – growing at a CAGR of 4.19%. The…

Continue Reading

MondaySep 25, 2023 10:53 am

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) Releases Significant Long-Term Survival Improvement Data from ALS Trial

Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc. are reporting on long-term follow-up data for participants in the HEALEY ALS Platform Trial; patients in the study were treated with CNM-Au8(R) 30mg for up to 133 weeks. According to the announcement, data from 59 patients shows prolonged life with 49% decreased risk of death for participants compared to PRO-ACT matched placebo over long-term follow-up; data also showed prolonged life with 59% decreased risk of death for participants in an integrated meta-analysis across HEALEY ALS Platform Trial and RESCUE-ALS Trial with CNM-Au8 30mg compared to PRO-ACT matched placebo over long-term follow-up.…

Continue Reading

MondaySep 25, 2023 10:30 am

Trial Enrollment Growth Supports Plans of CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) to Complete Enrollment for Important Brain Cancer Drug Study

CNS Pharmaceuticals is conducting a global clinical trial to evaluate its flagship drug candidate for treating glioblastoma, a deadly brain cancer CNS has enrolled 200 of its planned 243 patients for its clinical trial roster, and anticipates filling out the remainder of patients by year’s end The company is also preparing the interim study analysis for release by year’s end, now that more than 50 percent of the planned patient roster has reached a point necessary for effective comparison of performance of the flagship drug, Berubicin, to that of a standard of care chemotherapy agent The company has stated that…

Continue Reading

MondaySep 25, 2023 10:09 am

QualityStocksNewsBreaks – Near Intelligence Inc. (NASDAQ: NIR) Announces Seasoned Industry Veterans as New Board Members

Near Intelligence (NASDAQ: NIR), a data intelligence platform that curates one of the world’s largest sources of intelligence on people and places, has appointed two new members to its board of directors. According to the announcement, Richard J. Salute, a former director of Capital Markets and SEC Practice at J.H. Cohn and CohnReznick LLP, and Sherman Edmiston III, a managing member of HI CapM Advisors Ltd., have joined Near Intelligence’s board of directors, effective Sept. 19, 2023; a CPA, Salute will also serve as chair of the board audit committee. With more than 39 years of audit, accounting and tax experience,…

Continue Reading

MondaySep 25, 2023 9:45 am

Electronic Servitor Publication Network Inc. (XESP) Helps Businesses Compete and Win Through The Increasingly Recognized Necessity of Marketing Automation

XESP, through its Digital Engagement Engine(TM), is making automation, powerful data management, and an advanced workflow, more accessible to B2B companies The company allows businesses to offer buyers meaningful and empowering experiences, making them feel appreciated and understood, and moving them to action XESP understands businesses’ concerns, especially regarding the cost of automation, and continues to refine its products, integrating new features and addressing emerging customer needs, all at a more competitive price point By integrating new features and making new offerings, the company is staying ahead of the competition and stamping its position as a leader in the digital…

Continue Reading

MondaySep 25, 2023 9:14 am

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) K5 Security Robot Deployed in NYPD Pilot Program

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has announced that the city of New York and the New York Police Department (“NYPD”) launched the Knightscope K5 security robot service. The move was announced at a press conference with the support of the Metropolitan Transportation Authority (“MTA”). The first two weeks will be spent on training, configuration and setup protocols for the autonomous robot to navigate followed by patrol activities between the hours of 12:00 a.m. and 6:00 a.m. at the Times Square Subway Station. “Today we are launching a pilot program…

Continue Reading

MondaySep 25, 2023 9:00 am

GolfLync Inc.’s Pebble Beach Sweepstakes Ends October 1, 2023: This is Your Last Chance to Win a Dream Golf Trip to Pebble Beach Resorts

GolfLync, the leading social networking platform for golfers, is thrilled to remind you about the GolfLync Pebble Beach Sweepstakes, your golden opportunity to win the golf trip of a lifetime to the iconic Pebble Beach Resorts, acclaimed as the No. 1 Golf Resort in America. Pebble Beach Resorts, nestled on California's breathtaking Monterey Peninsula, offers an unparalleled golfing experience. With its three Top 50 public courses, including the world-famous Pebble Beach Golf Links, golf at Pebble Beach Resorts is an unforgettable journey. From the stunning coastal views at Spanish Bay to the majestic pines of Spyglass Hill, each course presents…

Continue Reading

FridaySep 22, 2023 3:45 pm

QualityStocksNewsBreaks – Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) Aspiring to Change the Face of the Oil and Gas Industry

Prospera (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B), a public oil and gas exploration, exploitation and development company focused on Western Canada, appears poised for record growth. This builds on “the success from 2022, when the company realized a net income of $3.1 million and experienced rapid growth when its revenue grew by a staggering 860% in Q2 2022. Prospera Energy expects significant reductions in production costs through 2024 and sizable increases in daily production. The company is currently exploring strategic acquisition targets to diversify Prospera heavy/light/gas product mix and path to 5,000 BPD over the next 24 months while expanding…

Continue Reading

FridaySep 22, 2023 2:34 pm

QualityStocksNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Making Significant Strides to Advance Cellular Therapy Programs

Longeveron (NASDAQ: LGVN) is a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-related Frailty. “The company is guided by the mission to advance cell-based product candidates into pivotal phase 3 trials, with the goal of attaining regulatory approvals and subsequently commercializing the product. Longeveron has so far made significant strides in line with this mission,” reads a recent article that discussed attendance by the company’s CEO Wa’el Hashad and EVP and CFO Lisa Locklear at the recent 25th Annual H.C. Wainwright Global Investment Conference. At the…

Continue Reading

FridaySep 22, 2023 1:57 pm

QualityStocksNewsBreaks – RVL Pharmaceuticals plc (NASDAQ: RVLP) Anticipating Growing Demand for UPNEEQ(R)

RVL Pharmaceuticals (NASDAQ: RVLP) is a a specialty pharmaceutical company whose near-term focus is to continue the rollout of UPNEEQ(R) into the medical aesthetics market through its dedicated sales force. “UPNEEQ(R) is the first non-surgical treatment option approved by the U.S. Food and Drug Administration (‘FDA’) for acquired blepharoptosis… UPNEEQ(R), the first and only FDA-approved eye drop for low-lying eyelids, fits into the non-invasive medical aesthetics category. With a single drop per day, clinical trials showed an average of one-millimeter lift to the upper eyelid, improving appearance and the superior visual field in patients with a functional deficit. Testing also…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered